Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  154 results for ""Cyclosporine""

Your Filters

Publisher : elsevier Subject : calcineurin inhibitors Subject : cyclosporin a Subject : kidney diseases Subject : mice Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.

  • Authors : Schlitt HJ; Klinik für Viszeral und Transplantationschirurgie, Medizinische Hochschule Hannover, Germany. ; Barkmann A

Subjects: Calcineurin Inhibitors* ; Liver Transplantation*; Cyclosporine/Cyclosporine/Cyclosporine/*therapeutic use

  • Source: Lancet (London, England) [Lancet] 2001 Feb 24; Vol. 357 (9256), pp. 587-91.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Role of cyclosporin A in the treatment of kidney disease and nephrotoxicity.

  • Authors : Yu J; Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China; Key Laboratory of Anti-Inflammatory and Immune Mdicine, Ministry of Education, Hefei, China

Subjects: Kidney Transplantation* ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/chemically induced ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/drug therapy

  • Source: Toxicology [Toxicology] 2023 Jun 15; Vol. 492, pp. 153544. Date of Electronic Publication: 2023 May 09.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0361055 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative safety of generic versus brand calcineurin inhibitors in solid organ transplant patients: A systematic review and meta-analysis.

Subjects: Calcineurin Inhibitors*/Calcineurin Inhibitors*/Calcineurin Inhibitors*/adverse effects ; Organ Transplantation*; Humans

  • Source: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2023 May-Jun; Vol. 63 (3), pp. 709-719. Date of Electronic Publication: 2023 Feb 10.Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

  • Authors : Rovin BH; Department of Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Teng YKO

Subjects: Calcineurin Inhibitors/Calcineurin Inhibitors/Calcineurin Inhibitors/*administration & dosage ; Cyclosporine/Cyclosporine/Cyclosporine/*administration & dosage ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*drug therapy

  • Source: Lancet (London, England) [Lancet] 2021 May 29; Vol. 397 (10289), pp. 2070-2080. Date of Electronic Publication: 2021 May 07.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not.

  • Authors : van Gelder T; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .

Subjects: Calcineurin Inhibitors*/Calcineurin Inhibitors*/Calcineurin Inhibitors*/adverse effects ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/drug therapy; Adult

  • Source: Kidney international [Kidney Int] 2021 Dec; Vol. 100 (6), pp. 1185-1189. Date of Electronic Publication: 2021 Jul 17.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Bioenergetic maladaptation and release of HMGB1 in calcineurin inhibitor-mediated nephrotoxicity.

  • Authors : Zmijewska AA; Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Zmijewski JW

Subjects: Calcineurin Inhibitors*/Calcineurin Inhibitors*/Calcineurin Inhibitors*/adverse effects ; HMGB1 Protein*; Animals

  • Source: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Sep; Vol. 21 (9), Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.

Subjects: Calcineurin Inhibitors/Calcineurin Inhibitors/Calcineurin Inhibitors/*administration & dosage ; Cyclosporine/Cyclosporine/Cyclosporine/*administration & dosage ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*drug therapy

  • Source: Kidney international [Kidney Int] 2019 Jan; Vol. 95 (1), pp. 219-231. Date of Electronic Publication: 2018 Nov 09.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Calcineurin inhibitors augment endothelial-to-mesenchymal transition by enhancing proliferation in association with cytokine-mediated activation.

  • Authors : Woda CB; The Transplant Research Program and the Division of Nephrology, Boston Children's Hospital, Boston, MA, 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA.

Subjects: Calcineurin Inhibitors/Calcineurin Inhibitors/Calcineurin Inhibitors/*pharmacology ; Cell Proliferation/Cell Proliferation/Cell Proliferation/*drug effects ; Epithelial-Mesenchymal Transition/Epithelial-Mesenchymal Transition/Epithelial-Mesenchymal Transition/*drug effects

  • Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2019 Nov 19; Vol. 519 (4), pp. 667-673. Date of Electronic Publication: 2019 Sep 18.Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.

Subjects: Calcineurin Inhibitors/Calcineurin Inhibitors/Calcineurin Inhibitors/*administration & dosage ; Graft Rejection/Graft Rejection/Graft Rejection/*prevention & control ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*administration & dosage

  • Source: Kidney international [Kidney Int] 2019 Jul; Vol. 96 (1), pp. 231-244. Date of Electronic Publication: 2019 Feb 27.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Tauroursodeoxycholic acid attenuates cyclosporine-induced renal fibrogenesis in the mouse model.

  • Authors : Groenendyk J; Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.; Robinson A

Subjects: Cyclosporine/Cyclosporine/Cyclosporine/*pharmacology ; Fibrosis/Fibrosis/Fibrosis/*chemically induced ; Kidney/Kidney/Kidney/*drug effects

  • Source: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2019 Jul; Vol. 1863 (7), pp. 1210-1216. Date of Electronic Publication: 2019 Apr 24.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731726 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  154 results for ""Cyclosporine""